Artículo
Different hierarchical reconfigurations in the brain by psilocybin and escitalopram for depression
Deco, Gustavo; Sanz Perl Hernandez, Yonatan
; Johnson, Samuel; Bourke, Niamh; Carhart Harris, Robin L.; Kringelbach, Morten L.
Fecha de publicación:
08/2024
Editorial:
Springer
Revista:
Nature Mental Health
ISSN:
2731-6076
Idioma:
Inglés
Tipo de recurso:
Artículo publicado
Clasificación temática:
Resumen
Effective interventions for neuropsychiatric disorders may work by rebalancing the brain’s functional hierarchical organization. Here we directly investigated the effects of two different serotonergic pharmacological interventions on functional brain hierarchy in major depressive disorder in a two-arm double-blind phase II randomized controlled trial comparing psilocybin therapy (22 patients) with escitalopram (20 patients). Patients with major depressive disorder received either 2 × 25 mg of oral psilocybin, three weeks apart, plus six weeks of daily placebo (‘psilocybin arm’) or 2 × 1 mg of oral psilocybin, three weeks apart, plus six weeks of daily escitalopram (10–20 mg; ‘escitalopram arm’). Resting-state functional magnetic resonance imaging scans were acquired at baseline and three weeks after the second psilocybin dose (NCT03429075). The brain mechanisms were captured by generative effective connectivity, estimated from whole-brain modeling of resting state for each session and patient. Hierarchy was determined for each of these sessions using measures of directedness and trophic levels on the effective connectivity, which captures cycle structure, stability and percolation. The results showed that the two pharmacological interventions created significantly different hierarchical reconfigurations of whole-brain dynamics with differential, opposite statistical effect responses. Furthermore, the use of machine learning revealed significant differential reorganization of brain hierarchy before and after the two treatments. Machine learning was also able to predict treatment response with an accuracy of 0.85 ± 0.04. Overall, the results demonstrate that psilocybin and escitalopram work in different ways for rebalancing brain dynamics in depression. This suggests the hypothesis that neuropsychiatric disorders could be closely linked to the breakdown in regions orchestrating brain dynamics from the top of the hierarchy.
Palabras clave:
Major Depression desorder
,
Psilocibyn
,
Neuroimaging
,
Brain hierarchy
Archivos asociados
Licencia
Identificadores
Colecciones
Articulos(SEDE CENTRAL)
Articulos de SEDE CENTRAL
Articulos de SEDE CENTRAL
Citación
Deco, Gustavo; Sanz Perl Hernandez, Yonatan; Johnson, Samuel; Bourke, Niamh; Carhart Harris, Robin L.; et al.; Different hierarchical reconfigurations in the brain by psilocybin and escitalopram for depression; Springer; Nature Mental Health; 2; 9; 8-2024; 1096-1110
Compartir
Altmétricas